MGMT and glioblastoma: Age, performance status, extent of resection, the presence of rapid early recurrence before radiotherapy, MGMT gene promoter methylation, ability to finish concomitant chemoradiotherapy, and adjuvant chemotherapy significantly influence the prognosis of glioblastoma patients.